Dengue vaccines: challenge and confrontation
GC Perng, HY Lei, YS Lin, K Chokephaibulkit - 2011 - repository.embuni.ac.ke
Dengue has been recognized as one of the most important vector-borne human diseases.
The disease is induced by dengue virus infection resulting from the bite of an infected Aedes …
The disease is induced by dengue virus infection resulting from the bite of an infected Aedes …
[HTML][HTML] Dengue vaccines: challenges, development, current status and prospects
Infection with dengue virus (DENV) is the most rapidly spreading mosquito-borne viral
disease in the world. The clinical spectrum of dengue, caused by any of the four serotypes of …
disease in the world. The clinical spectrum of dengue, caused by any of the four serotypes of …
Dengue vaccine development: strategies and challenges
L Ramakrishnan, M Radhakrishna Pillai… - Viral immunology, 2015 - liebertpub.com
Infection with dengue virus may result in dengue fever or a more severe outcome, such as
dengue hemorrhagic syndrome/shock. Dengue virus infection poses a threat to endemic …
dengue hemorrhagic syndrome/shock. Dengue virus infection poses a threat to endemic …
Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art
J Pintado Silva… - Journal of General …, 2023 - microbiologyresearch.org
Dengue virus (DENV) is the mosquito-borne virus of greatest human health concern. There
are four serotypes of DENV (1-4) that co-circulate in endemic areas. Each serotype of DENV …
are four serotypes of DENV (1-4) that co-circulate in endemic areas. Each serotype of DENV …
Dengue vaccines: recent developments, ongoing challenges and current candidates
MA McArthur, MB Sztein, R Edelman - Expert review of vaccines, 2013 - Taylor & Francis
Dengue is among the most prevalent and important arbovirus diseases of humans. To
effectively control this rapidly spreading disease, control of the vector mosquito and a safe …
effectively control this rapidly spreading disease, control of the vector mosquito and a safe …
Consultation on dengue vaccines: progress in understanding protection, 26–28 June 2013, Rockville, Maryland
MC Cassetti, SB Halstead - Vaccine, 2014 - Elsevier
There is an unmet need for a dengue vaccine to further prevent the spread of this disease
and contain the growing pandemic. To this end several vaccine companies and academic …
and contain the growing pandemic. To this end several vaccine companies and academic …
Vaccines for the prevention of dengue: development update
SJ Thomas, TP Endy - Human vaccines, 2011 - Taylor & Francis
The dengue viruses (DENV) are mosquito-borne flaviviruses which cause a spectrum of
clinical disease known as “dengue,” and have emerged and re-emerged as a significant …
clinical disease known as “dengue,” and have emerged and re-emerged as a significant …
Dengue vaccine: priorities and progress
MG Guzman, M Muné, G Kourí - Expert Review of Anti-Infective …, 2004 - Taylor & Francis
Dengue transmission has increased considerably in the past 20 years. Currently, it can only
be reduced by mosquito control; however, the application of vector-control methods are …
be reduced by mosquito control; however, the application of vector-control methods are …
Dengue vaccines: progress and challenges
BAG Coller, DE Clements - Current opinion in immunology, 2011 - Elsevier
With several dengue vaccine candidates progressing through clinical trials, several options
for controlling this disease appear feasible. This would represent a major achievement and …
for controlling this disease appear feasible. This would represent a major achievement and …
Critical issues in dengue vaccine development
SJ Thomas, TP Endy - Current opinion in infectious diseases, 2011 - journals.lww.com
Critical issues in dengue vaccine development : Current Opinion in Infectious Diseases Critical
issues in dengue vaccine development : Current Opinion in Infectious Diseases Log in or …
issues in dengue vaccine development : Current Opinion in Infectious Diseases Log in or …